newsfilter
← Latest News
GlobeNewswire·

Sigyn Therapeutics™ Discloses In-Vitro Viral Pathogen Study

Sigyn Therapy™ demonstrates the ability to address viral pathogens, including SARS-CoV-2 (COVID-19) SAN DIEGO, April 21, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), a medical technology company fo